Skip to content

Development of Digital Angiography Equipment and Software for Precision Diagnosis and Treatment of Cerebrovascular Diseases — Research on Transarterial Head and Neck CTA Imaging Technology Based on Sliding Rail CT and a Comparative Study of Thrombectomy Guided by CTA-DSA Image Fusion versus Conventional Thrombectomy

Development of Digital Angiography Equipment and Software for Precision Diagnosis and Treatment of Cerebrovascular Diseases — Research on Transarterial Head and Neck CTA Imaging Technology Based on Sliding Rail CT and a Comparative Study of Thrombectomy Guided by CTA-DSA Image Fusion versus Conventional Thrombectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128645
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Treatment group:One-stop thrombectomy guided by sliding rail CT
Conventional group:Conventional thrombectomy group

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–60 years; 2.Clinical diagnosis of acute ischemic stroke and eligibility for immediate endovascular treatment; 3.Time from symptom onset/last known well <= 24 hours; 4.Completed intravenous head and neck CTA imaging examination; 5.Confirmation of an occluded vessel amenable to endovascular intervention based on the results of intravenous head and neck CTA imaging; 6.Written informed consent obtained from the patient or their legally authorized representative;

Exclusion criteria

Exclusion criteria: 1.Contrast medium allergy; 2.Renal insufficiency with eGFR = 185 mmHg or diastolic blood pressure >= 110 mmHg) (Note: patients may be enrolled if blood pressure is successfully reduced and maintained at an acceptable level with medication); 7.Imaging findings indicating conditions unsuitable for endovascular intervention, such as space-occupying lesions in the brain; 8.Patients with other severe comorbidities or complications that may affect the conduct or evaluation of this study;

Design outcomes

Primary

MeasureTime frame
Time from puncture to successful recanalization (PRT);

Secondary

MeasureTime frame
First-pass recanalization rate;

Countries

China

Contacts

Public ContactWang Yongjun

Beijing Tiantan Hospital, Capital Medical University

13811355059@139.com+86 10 59978538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026